Fate Therapeutics reports Q4 results
Source: SeekingAlpha
2026-02-26 10:16:24 ET
More on Fate Therapeutics
- Seeking Alpha’s Quant Rating on Fate Therapeutics
- Historical earnings data for Fate Therapeutics
- Financial information for Fate Therapeutics
Read the full article on Seeking Alpha
For further details see:
Fate Therapeutics reports Q4 results
Fate Therapeutics Inc.
NASDAQ: FATE
FATE Trading
6.25% G/L:
$1.53 Last:
1,030,818 Volume:
$1.55 Open:
FATE Latest News
February 26, 2026 09:00:00 am
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
February 16, 2026 01:00:00 pm
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
January 23, 2026 12:56:22 pm
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
FATE Stock Data
$128,041,041
108,996,378
1.54%
45
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
